Technologies

 

Graftoss’s bone matrix technology has applications as a xenograft material for human and veterinary grafting, including spinal fusion, hand and foot surgery, simple and complex fractures repair, joint reconstruction and dental implants, and as an antibiotic impregnated graft material for application in conditions such as osteomyelitis.

Graftoss’s bone matrix technology offers several advantages:

• Bovine bone sourced from New Zealand is free from BSE
• Retention of the macro and micro porous structures ensures good biocompatibility.
• The creation of a high value medical device from an otherwise waste / low value product.
• The sintering process effectively sterilises the bone to guarantee the product is completely free of prions and other patho gens and diseases, such as HIV or hepatitis.
• The sintered bone is reinforced by a biocompatible organic matrix, which strengthens the bone and creates a structure that is conducive for bone regeneration.
• The device can be used to deliver therapeutics to the bone repair site.

To make an enquiry please click here.